
VR tool to trial IOL options
VirtuaLens announced the launch of the Immersive IOL Simulator, described as a virtual reality (VR) platform to help cataract patients explore and compare intraocular lens (IOL) options before surgery
4201 articles

VirtuaLens announced the launch of the Immersive IOL Simulator, described as a virtual reality (VR) platform to help cataract patients explore and compare intraocular lens (IOL) options before surgery

LINK: https://www.nzoptics.co.nz/live-articles/new-board-members-appointed/

An Israeli study found topical beta-blockers used to treat glaucoma were not associated with an increased risk of Parkinson’s disease (PD). Writing in the British Journal of Ophthalmology, autho

Ashvattha Therapeutics reported the results of a phase 2 trial of migaldendranib (MGB), its monthly ‘at-home’ subcutaneous anti-VEGF injection, showed it reduced treatment burden and improved visual a

LINK: https://www.nzoptics.co.nz/live-articles/optometry-s-salary-ceiling/


A large Chinese study found shorter leucocyte telomere length (LTL) was associated with increased risk of age-related macular degeneration (AMD) in females. Writing in the British Journal of Opht

Contemporary Australian eyewear brand Aiko embodies a love for diverse global cultures, blending aesthetic principles from various regions into a harmonious and colourful collection. Lightweight and e



https://www.nzoptics.co.nz/live-articles/pbm-for-amd-now-in-nz/

A recent pilot showed strengthened referral pathways increase access to support for people living with low vision or blindness.